Recent data on hypertension and progressive renal disease.

Arterial hypertension may favour the progression of non-diabetic primary renal disease and participate in the appearance of atheromatous renovascular disease. In AIPRI trial (ACE-inhibition in the progression of renal insufficiency) the ACE-inhibitor benazepril was able to protect patients with mild-to-moderate renal disease against the progression of renal insufficiency. Some clinical observations suggest that in many aged patients with long-standing hypertension the appearance of renal failure may be related to atheromatous reno-vascular disease. This disease may be responsible for progressive renal failure through renal artery stenosis and/or cholesterol microembolization.
AuthorsP Zucchelli, A Zuccalà
JournalJournal of human hypertension (J Hum Hypertens) Vol. 10 Issue 10 Pg. 679-82 (Oct 1996) ISSN: 0950-9240 [Print] ENGLAND
PMID9004094 (Publication Type: Journal Article, Review)
  • Disease Progression
  • Humans
  • Hypertension (complications, drug therapy)
  • Renal Insufficiency (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: